LYNCH DANIEL 4
4 · SpringWorks Therapeutics, Inc. · Filed May 25, 2023
Insider Transaction Report
Form 4
LYNCH DANIEL
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-24+13,774→ 13,774 totalExercise: $32.27Exp: 2033-05-24→ Common Stock (13,774 underlying) - Award
Common Stock
2023-05-24+4,648→ 301,849 total
Footnotes (3)
- [F1]This transaction represents a grant of restricted stock units ("RSUs") pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders. The RSUs shall vest in full on the earlier of (1) May 24, 2024 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.
- [F2]This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's annual meeting of stockholders.
- [F3]The options shall vest in full on the earlier of (1) May 24, 2024 and (2) the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.